$CYTR CYTRX CORP Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CYTRX CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in CYTRX CORP. Find out how many shares they currently own, their value and whether they buy or sell their shares.
CYTRX CORP Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
Barber Jack R | Sr VP - Drug Development | 0 | 0 | May 19 2005 | |||
Barber Jack R | Chief Scientific Officer | 0 | 0 | Nov 24 2008 | |||
Barber Jack R | Chief Scientific Officer | 0 | 0 | Apr 08 2008 | |||
Barber Jack R | Chief Scientific Officer | 0 | 0 | Jul 06 2009 | |||
Brien Earl W | Director | 590,247 | 247,904 | Aug 20 2020 | |||
Caldwell Joel K | Director | 510,000 | 214,200 | Aug 13 2020 | |||
CALOZ JOHN Y | Chief Financial Officer | 0 | 0 | Dec 17 2019 | |||
CALOZ JOHN Y | Chief Financial Officer | 0 | 0 | Jan 06 2009 | |||
CALOZ JOHN Y | Chief Accounting Officer | 0 | 0 | Apr 08 2008 | |||
CALOZ JOHN Y | Chief Accounting Officer | 0 | 0 | Nov 24 2008 | |||
CALOZ JOHN Y | Chief Accounting Officer | 0 | 0 | Jul 06 2009 | |||
CALOZ JOHN Y | Chief Financial Officer | 0 | 0 | Dec 16 2010 | |||
CALOZ JOHN Y | Chief Financial Officer | 31,792 | 13,353 | Dec 11 2013 | |||
CALOZ JOHN Y | Chief Financial Officer | 0 | 0 | Dec 17 2014 | |||
CAPPELLO ALEXANDER L | Director | 0 | 0 | Oct 17 2003 | |||
CARNAHAN RAYMOND C JR | 0 | 0 | Oct 17 2003 | ||||
Chawla Anita J | Director | 0 | 0 | Dec 19 2016 | |||
Cohen Cheryl | Director | 0 | 0 | Dec 17 2015 | |||
CYTRX CORP | 10% Owner | 0 | 0 | Dec 30 2010 | |||
FOGELMAN MITCHELL K | Chief Financial Officer | 0 | 0 | Apr 08 2008 | |||
FOGELMAN MITCHELL K | Chief Financial Officer | 0 | 0 | Nov 24 2008 | |||
Geyer David Scott | Sr. V.P. of Manufacturing | 0 | 0 | Dec 13 2011 | |||
IGNARRO LOUIS | Director | 872,427 | 366,419 | Aug 13 2020 | |||
IGNARRO LOUIS | Director | 0 | 0 | Jul 06 2009 | |||
IGNARRO LOUIS | Director | 0 | 0 | Dec 16 2014 | |||
Kratz Felix | Vice President Drug Discovery | 0 | 0 | Jan 02 2018 | |||
KRIEGSMAN STEVEN A | Chief Executive Officer | 4,832,217 | 2,029,531 | Aug 13 2020 | |||
KRIEGSMAN STEVEN A | Chief Executive Officer | 4,179,776 | 1,755,506 | Feb 24 2012 | |||
KRIEGSMAN STEVEN A | President, CEO, Board Chairman | 0 | 0 | Dec 16 2014 | |||
KRIEGSMAN STEVEN A | Chief Executive Officer | 4,021,100 | 1,688,862 | Dec 11 2013 | |||
KRIEGSMAN STEVEN A | Chief Executive Officer | 0 | 0 | Jul 06 2009 | |||
KRIEGSMAN STEVEN A | Chief Executive Officer | 0 | 0 | Mar 12 2013 | |||
Levin Ben | SVP-Legal Affairs/GC/Secy | 33,578 | 14,103 | Dec 17 2015 | |||
Levin Ben | GC/VP Legal Affairs/Secy | 0 | 0 | Jul 06 2009 | |||
Levin Ben | GC/SVP-Legal Affairs/Secy | 0 | 0 | Dec 17 2014 | |||
LEVITT DANIEL J | EVP and Chief Medical Officer | 0 | 0 | Dec 19 2016 | |||
LEVITT DANIEL J | EVP and Chief Medical Officer | 200,000 | 84,000 | Dec 12 2013 | |||
LEVITT DANIEL J | Chief Medical Officer | 0 | 0 | Dec 16 2010 | |||
LEVITT DANIEL J | EVP and Chief Medical Officer | 214,286 | 90,000 | Dec 17 2014 | |||
LINK MAX | Director | 54,976 | 23,090 | May 01 2007 | |||
LINK MAX | Director | 0 | 0 | Jul 12 2007 | |||
LINK MAX | Director | 0 | 0 | Jul 09 2008 | |||
LINK MAX | Director | 0 | 0 | Jul 06 2009 | |||
LINK MAX | Director | 0 | 0 | Dec 12 2013 | |||
LINK MAX | Director | 260,305 | 109,328 | Feb 24 2012 | |||
LINK MAX | Director | 0 | 0 | May 15 2012 | |||
LINK MAX | Director | 0 | 0 | Aug 12 2004 | |||
MCDADE HERBERT H JR | 0 | 0 | Oct 17 2003 | ||||
Natalizio Matt | Chief Financial Officer | 0 | 0 | Jun 21 2006 | |||
Ng Shi Chung | Sr VP Research & Development | 0 | 0 | Nov 24 2008 | |||
Patterson Scott Bradford | 10% Owner | 4,577,605 | 1,922,594 | Dec 12 2013 | |||
RUBINFELD JOSEPH | Director | 0 | 0 | Dec 19 2016 | |||
RUBINFELD JOSEPH | Director | 0 | 0 | Dec 16 2014 | |||
RUBINFELD JOSEPH | Director | 0 | 0 | Jul 19 2005 | |||
RUBINFELD JOSEPH | Director | 0 | 0 | Jul 12 2007 | |||
RUBINFELD JOSEPH | Director | 0 | 0 | Jul 02 2008 | |||
RUBINFELD JOSEPH | Director | 0 | 0 | Jul 06 2009 | |||
RUBINFELD JOSEPH | Director | 0 | 0 | Dec 12 2013 | |||
RUBINFELD JOSEPH | Director | 0 | 0 | May 15 2012 | |||
SELTER ERIC JAY | Director | 0 | 0 | Dec 17 2015 | |||
SELTER MARVIN R | Director | 253,193 | 106,341 | Dec 12 2013 | |||
SELTER MARVIN R | Director | 0 | 0 | Jul 06 2009 | |||
Tepper Mark | Vice President | 0 | 0 | May 10 2007 | |||
Ware Olivia C | Chief Commercial Officer | 0 | 0 | Jan 14 2016 | |||
WENNEKAMP RICHARD J | Director | 5,000 | 2,100 | Jul 03 2008 | |||
Wennekamp Richard L. | Director | 0 | 0 | Jul 06 2009 | |||
Wennekamp Richard L. | Director | 116,965 | 49,125 | Dec 12 2013 | |||
Wennekamp Richard L. | Director | 0 | 0 | Dec 16 2014 | |||
Wieland Douglas Scott | Sr VP - Drug Development | 0 | 0 | Dec 19 2016 | |||
Wieland Douglas Scott | Sr. VP - Drug Development | 0 | 0 | Jul 06 2009 | |||
Wieland Douglas Scott | Sr VP - Drug Development | 0 | 0 | Dec 17 2014 |